Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04850066
Other study ID # 2018-A00022-53
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2021
Est. completion date March 9, 2023

Study information

Verified date February 2024
Source Centre Hospitalier de Dreux
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the efficacy of a brief equine-assisted intervention on the social adjustment, assertiveness, self-esteem and coping strategies in adult patients with psychosocial dysfunction, hospitalized and followed in psychiatry, as compared to standard care.


Recruitment information / eligibility

Status Completed
Enrollment 98
Est. completion date March 9, 2023
Est. primary completion date March 9, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: Patients hospitalized in psychiatry with mental disorders lasting for more than 6 months with an EGF score on the Global Evaluation of Psychosocial Functioning scale of between 31 and 60 at the time of inclusion. Exclusion Criteria: - acute psychiatric crisis - severe comorbidities (such as mental retardation, mental deterioration) which could invalidate informed consent or limit patient compliance with the study protocol. - medical contraindication to equine-assisted therapy (allergy, immunocompromised patients) - pregnancy - no affiliation to a social security scheme - deprivation of liberty by a judicial decision - wardship - horse phobia

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Equine-assisted intervention
Usual care including an equine-assisted intervention carried out on foot, next to the horse, in 3 sessions of 3 hours each, spread over 4 weeks. This program is based on self-awareness, communication, assertiveness and adaptability.

Locations

Country Name City State
France Centre Hospitalier Victor Jousselin Dreux

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier de Dreux

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Social adjustment (self reported) Change in the score of the SAS-SR (social adjustment scale -self report) (from 1 (excellent adjustment) to 5 (bad adjustment)) Baseline and 6 months
Primary Social adjustment Change in the score of the SAS (social adjustment scale) (from 1 (excellent adjustment) to 5 (bad adjustment)) Baseline and 6 months
Secondary Assertiveness Change in the score of the Rathus assertiveness schedule (from -90 (difficulties of assertivity) to +90 (good assertivity)) Baseline, 2 and 6 months
Secondary Self-esteem Change in the score of the Rosenberg's Self-Esteem scale (from 10 to 40). Baseline, 2 and 6 months
Secondary Ways of coping Change in the score of the Ways of coping checklist (from 27 to 108). Baseline, 2 and 6 months
See also
  Status Clinical Trial Phase
Completed NCT06393491 - Equine-assisted Therapy and Anorexia Nervosa
Not yet recruiting NCT06303596 - Hippotherapy in Patients With Schizophrenia N/A
Completed NCT04885023 - Efficacy Hippotherapy on Postural Asymmetries and Balance in Adolescents With Idiopathic Scoliosis N/A
Completed NCT06057311 - Equine Assisted Therapy in Autism Spectrum Disorder N/A